RedHill Biopharma (Global Rights to Movantik) Overview

  • Status
  • Private

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

RedHill Biopharma (Global Rights to Movantik) General Information

Description

The global rights to Movantik excluding Europe, Canada and Israel.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 1 Francis Crick Avenue
  • Cambridge Biomedical Campus
  • Cambridge CB2 0AA
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RedHill Biopharma (Global Rights to Movantik) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore RedHill Biopharma (Global Rights to Movantik)‘s full profile, request access.

Request a free trial

RedHill Biopharma (Global Rights to Movantik) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore RedHill Biopharma (Global Rights to Movantik)‘s full profile, request access.

Request a free trial

RedHill Biopharma (Global Rights to Movantik) FAQs

  • Where is RedHill Biopharma (Global Rights to Movantik) headquartered?

    RedHill Biopharma (Global Rights to Movantik) is headquartered in Cambridge, United Kingdom.

  • What industry is RedHill Biopharma (Global Rights to Movantik) in?

    RedHill Biopharma (Global Rights to Movantik)’s primary industry is Buildings and Property.

  • Is RedHill Biopharma (Global Rights to Movantik) a private or public company?

    RedHill Biopharma (Global Rights to Movantik) is a Private company.

  • What is the current valuation of RedHill Biopharma (Global Rights to Movantik)?

    The current valuation of RedHill Biopharma (Global Rights to Movantik) is .

  • What is RedHill Biopharma (Global Rights to Movantik)’s current revenue?

    The current revenue for RedHill Biopharma (Global Rights to Movantik) is .

  • Who are RedHill Biopharma (Global Rights to Movantik)’s investors?

    HCRx has invested in RedHill Biopharma (Global Rights to Movantik).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process